StockWatch
·
Pharmaceuticals
Management Change18 Jun 2026, 09:40 pm

Alembic Pharma Appoints Sujit Bhayani as Independent Director

AI Summary

Alembic Pharmaceuticals Ltd has announced the appointment of Mr. Sujit Bhayani as a Non-Executive Independent Director, effective June 18, 2026. The appointment, approved by the Board of Directors via circular resolution upon recommendation from the Nomination and Remuneration Committee, is for a term of five years, subject to shareholder approval at the upcoming Annual General Meeting. Mr. Bhayani brings over 35 years of experience in the pharmaceuticals industry and is the Founder and Managing Director of the Sudeep Group. He is not related to any existing directors or key managerial personnel of the company.

Key Highlights

  • Sujit Bhayani appointed as Non-Executive Independent Director.
  • Appointment effective June 18, 2026, for a 5-year term.
  • Subject to shareholder approval at the ensuing AGM.
  • Bhayani has 35+ years of pharma industry experience.
  • Not related to current directors or KMPs.